Inotiv, Inc. — Director's Dealing 2012

Mar 23, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2012-03-15

Reporting Person: Payne Lori (VP Bioanalytical Services)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to Purchase Common Shares	$5.74	2015-07-26	Common Shares (5000)		Direct
Option to Purchase Common Shares	$5.09	2018-09-04	Common Shares (5000)		Direct
Option to Purchase Common Shares	$1.01	2020-08-16	Common Shares (10000)		Direct

Footnotes

F1: 1,250 options vested and became exercisable on each of July 26, 2007, 2008, 2009 and 2010.

F2: 1,250 options vested and became exercisable on each of September 4, 2010 and 2011 and 1,250 options will vest and become exercisable on each of September 4, 2012 and 2013.

F3: 2,500 options will vest and become exercisable on each of August 16, 2012, 2013, 2014 and 2015.